Looking forward to delving deeper into the reasons why young breast cancer survivors experience less weight loss with weight loss interventions and more weight gain after a breast cancer diagnosis 🔎
In this study we evaluated the relationship of TILs w/ clinical characteristics + prognosis in women 40 & under with HR+ breast cancer🔎 Most TIL subtypes were associated with improved outcomes, suggesting immune biomarkers could be a valuable tool in future for young patients⭐️
@LGMartelotto Good luck on your next steps, Lu! You’re one of the best, friendliest, and innovative scientist I’ve worked with! If you ever need someone to chat to, I’m always here my friend!
This evening, the 33 members of the 2025 class of AACR Fellows were inducted into the AACR Academy. The distinguished scientists who comprise the AACR Academy serve as a global brain trust, providing scientific leadership to advance the AACR's mission. #AACR25
This is a landmark approval based on years of incredible basic science. Congrats to all involved and particularly Stuart Orkin who, over decades, drove the fundamental research in globin regulation that got us to this point!
@UrnovFyodor @JohnDoench @nathanwpyle@dccc_phd Even though Tim Horton 🇨🇦 isn’t much better, I align with this statement! As a transplant in Boston, I should probably double lock my doors tonight. Correct me if I’m wrong, but VEGFA_site2 is going to clinic, right? 😂 (totally kidding)
Beautiful presentation by @MeganTesch on TILs and outcomes in younger patients with ER+ breast cancer
Most TIL subtypes assoc with improved breast cancer outcomes
More work needed to see if TIL could help risk stratify in this subgroup
@DFCI_BreastOnc@OncoAlert#ASCO23
Who else thinks the @trailerparkboys should lace up with Marchy as honorary enforcers to defend @37_Bergeron from cheap shots 3 seconds after the whistle? At least get them there behind the bench to get the B’s fired up! #LetsGo#StanleyCup@NHLBruins